6-Deoxyoxaunomycin
Alternative Names: 6-Deoxy-D788-7Latest Information Update: 21 Oct 1997
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 21 Oct 1997 No-Development-Reported for Cancer in Japan (Unknown route)
- 06 Jul 1995 New profile
- 30 Jun 1995 Preclinical development for Cancer in Japan (Unknown route)